D-Index & Metrics Best Publications
Ruey-Bing Yang

Ruey-Bing Yang

Academia Sinica
Taiwan, Province of China

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

The scientist’s investigation covers issues in Signal transduction, Cell biology, Receptor, Molecular biology and Toll-like receptor. Ruey-Bing Yang focuses mostly in the field of Signal transduction, narrowing it down to topics relating to Cancer research and, in certain cases, Metastasis, Breast carcinoma, Small hairpin RNA and Metastatic breast cancer. His Cell biology study combines topics from a wide range of disciplines, such as Cyclase activity, Cyclase, Biochemistry, Immunology and Innate immune system.

His study in the fields of Adenylyl cyclase under the domain of Receptor overlaps with other disciplines such as Fibroblast growth factor receptor 4, P2Y receptor and P2Y12. His Molecular biology study combines topics in areas such as Epidermal growth factor, Angiogenesis, Gene expression, Complementary DNA and Endothelium. The concepts of his Toll-like receptor study are interwoven with issues in Inflammation and TLR2.

His most cited work include:

  • Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. (1527 citations)
  • Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2 (1380 citations)
  • Identification of the platelet ADP receptor targeted by antithrombotic drugs. (1219 citations)

What are the main themes of his work throughout his whole career to date?

Ruey-Bing Yang focuses on Molecular biology, Cell biology, Receptor, Internal medicine and Cancer research. His work carried out in the field of Molecular biology brings together such families of science as Epidermal growth factor, Messenger RNA and Sperm, Acrosome, Gamete. He has included themes like Epithelial–mesenchymal transition, Toll-like receptor, Bioinformatics and Osteoblast in his Cell biology study.

His study connects Signal transduction and Receptor. Ruey-Bing Yang usually deals with Internal medicine and limits it to topics linked to Endocrinology and Extracellular, Transgene and Kinase. His Cancer research research incorporates themes from Tumor necrosis factor alpha, Cell growth, Metastasis, Acute kidney injury and Breast cancer.

He most often published in these fields:

  • Molecular biology (55.37%)
  • Cell biology (50.41%)
  • Receptor (47.11%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (31.40%)
  • Receptor (47.11%)
  • Growth factor (16.53%)

In recent papers he was focusing on the following fields of study:

Ruey-Bing Yang mostly deals with Cancer research, Receptor, Growth factor, Molecular biology and Cell biology. His biological study spans a wide range of topics, including Inflammation, Downregulation and upregulation, Epidermal growth factor receptor and Tumor necrosis factor alpha. His Receptor research is multidisciplinary, incorporating elements of Endocrinology, Heterologous expression, Bone morphogenetic protein and Bone morphogenetic protein 2.

His work carried out in the field of Growth factor brings together such families of science as Thrombin and Thromboxane A2. His Molecular biology research is multidisciplinary, relying on both Platelet activation, Platelet, Epidermal growth factor and Thrombus. He combines subjects such as Phenotype, Vascular endothelial growth factor and Kinase insert domain receptor with his study of Cell biology.

Between 2017 and 2021, his most popular works were:

  • PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis. (65 citations)
  • Guanylyl cyclase‐G is an alarm pheromone receptor in mice (13 citations)
  • Guanylyl cyclase‐G is an alarm pheromone receptor in mice (13 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Cancer

Ruey-Bing Yang mainly investigates Cell biology, Internal medicine, Heterologous expression, Olfaction and Corticosterone. His Cell biology study incorporates themes from Vascular endothelial growth factor, VEGF receptors and Tumor angiogenesis. His work on Receptor and Transmembrane protein as part of general Internal medicine study is frequently linked to Grueneberg ganglion, therefore connecting diverse disciplines of science.

His Heterologous expression study frequently involves adjacent topics like Endocrinology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.

Hans D. Brightbill;Daniel H. Libraty;Stephan R. Krutzik;Ruey Bing Yang.
Science (1999)

2154 Citations

Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2

Antonios O. Aliprantis;Ruey-Bing Yang;Melanie R. Mark;Shelly Suggett.
Science (1999)

1889 Citations

Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Gunther Hollopeter;Hans-Michael Jantzen;Diana Vincent;Georgia Li.
Nature (2001)

1772 Citations

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

Ruey-Bing Yang;Melanie R. Mark;Alane Gray;Arthur Huang.
Nature (1998)

1599 Citations

The apoptotic signaling pathway activated by Toll-like receptor-2.

Antonios O. Aliprantis;Ruey‐Bing Yang;David S. Weiss;Paul Godowski.
The EMBO Journal (2000)

580 Citations

Signaling Events Induced by Lipopolysaccharide-Activated Toll-Like Receptor 2

Ruey-Bing Yang;Melanie R. Mark;Austin L. Gurney;Paul J. Godowski.
Journal of Immunology (1999)

351 Citations

A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons.

Hans-Jurgen Fulle;Robert Vassar;David C. Foster;Ruey-Bing Yang.
Proceedings of the National Academy of Sciences of the United States of America (1995)

328 Citations

Two membrane forms of guanylyl cyclase found in the eye.

Ruey-Bing Yang;David C. Foster;David L. Garbers;Hans-Jurgen Fulle.
Proceedings of the National Academy of Sciences of the United States of America (1995)

283 Citations

Mutations in the Retinal Guanylate Cyclase (RETGC-1) Gene in Dominant Cone-Rod Dystrophy

Rosemary E. Kelsell;Kevin Gregory-Evans;Annette M. Payne;Isabelle Perrault.
Human Molecular Genetics (1998)

259 Citations

Disruption of a Retinal Guanylyl Cyclase Gene Leads to Cone-Specific Dystrophy and Paradoxical Rod Behavior

Ruey Bing Yang;Susan W. Robinson;Wei Hong Xiong;King Wai Yau.
The Journal of Neuroscience (1999)

220 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ruey-Bing Yang

Shizuo Akira

Shizuo Akira

Osaka University

Publications: 87

Douglas T. Golenbock

Douglas T. Golenbock

University of Massachusetts Medical School

Publications: 52

Alexander M. Dizhoor

Alexander M. Dizhoor

Salus University

Publications: 49

Robert L. Modlin

Robert L. Modlin

University of California, Los Angeles

Publications: 48

Osamu Takeuchi

Osamu Takeuchi

Kyoto University

Publications: 40

Christian Gachet

Christian Gachet

University of Strasbourg

Publications: 37

Carsten J. Kirschning

Carsten J. Kirschning

University of Duisburg-Essen

Publications: 34

Geoffrey Burnstock

Geoffrey Burnstock

University of Melbourne

Publications: 33

Wolfgang Baehr

Wolfgang Baehr

University of Utah

Publications: 32

Kiyoshi Takeda

Kiyoshi Takeda

Osaka University

Publications: 32

Satya P. Kunapuli

Satya P. Kunapuli

Temple University

Publications: 28

Egil Lien

Egil Lien

University of Massachusetts Medical School

Publications: 28

Krzysztof Palczewski

Krzysztof Palczewski

University of California, Irvine

Publications: 27

Marco Cattaneo

Marco Cattaneo

University of Milan

Publications: 26

Kenneth A. Jacobson

Kenneth A. Jacobson

National Institutes of Health

Publications: 26

Hermann Wagner

Hermann Wagner

Technical University of Munich

Publications: 25

Trending Scientists

Anatoly Vershik

Anatoly Vershik

St Petersburg University

Xiuping Jia

Xiuping Jia

University of New South Wales

Junfeng Bai

Junfeng Bai

Shaanxi Normal University

Shin Takahashi

Shin Takahashi

Ehime University

Alan J. Russell

Alan J. Russell

Carnegie Mellon University

Roger Frech

Roger Frech

University of Oklahoma

Seung Wook Kim

Seung Wook Kim

Korea University

Linda M. Brzustowicz

Linda M. Brzustowicz

Rutgers, The State University of New Jersey

David A. Hinds

David A. Hinds

Stanford University

Peter V. Kharchenko

Peter V. Kharchenko

Harvard University

Charles C. Krueger

Charles C. Krueger

Michigan State University

Gavan P. McNally

Gavan P. McNally

University of New South Wales

Sabina Signoretti

Sabina Signoretti

Brigham and Women's Hospital

Yves Dauvilliers

Yves Dauvilliers

University of Montpellier

Samuel Singer

Samuel Singer

Memorial Sloan Kettering Cancer Center

Ralf Launhardt

Ralf Launhardt

Max Planck Society

Something went wrong. Please try again later.